
Trendler
Kurallar
This market will resolve to "Yes" if it is officially announced that a Biologics License Application (BLA) for intismeran autogene has been submitted to the U.S. Food and Drug Administration (FDA), or that the FDA has accepted such an application for review, by June 30, 2027, 11:59 PM ET.
+2 daha fazla sonuç
+1 daha fazla sonuç
+2 daha fazla sonuç